
After attending an industry dinner, urologist Henry Rosevear, MD, came away with an appreciation for the role of health care economics in bringing a product to market.

After attending an industry dinner, urologist Henry Rosevear, MD, came away with an appreciation for the role of health care economics in bringing a product to market.

In this Urology Times educational supplement, we review the importance of understanding the CRPC–mCRPC transition in order to optimize standard screening procedures and identify patients with early metastatic disease who may benefit from therapeutic intervention.

There are several options for saving for retirement, but first develop a good understanding of how these retirement accounts work to get the most out of your savings.

The development of a model for identifying prostate cancer patients who may be appropriate candidates for hemi-ablative focal therapy remains a work in progress for researchers at Memorial Sloan Kettering Cancer Center.

Researchers from Wake Forest Baptist Comprehensive Cancer Center have made novel discoveries about the genomic signatures of cancers-including bladder cancer-in smokers and African-American patients.

New research characterizing the molecular mechanisms regulating immune cell infiltration into the luminal subtype of muscle-invasive bladder cancer may explain resistance to treatment with immune checkpoint blockade and suggest a target for improving therapeutic response.

The following letter was sent to Urology Times in response to a previously published letter to the editor, "Dear USPSTF: Don't discount value of PSA in men 70+."

Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.

Authors of a recent study say that long-term therapy with a 5-alpha-reductase inhibitor was associated with increased glucose, increased glycated hemoglobin, and altered lipid profiles.

In this interview, SUNA President Gwendolyn Hooper, PhD, APRN, discusses practical tips for prevention and management of incontinence in men treated for localized prostate cancer.

In this interview, Leonard G. Gomella, MD, provides an update on prostate cancer genetics, discusses the recent Prostate Cancer International Consensus Conference, and outlines why urologists should conduct more extensive family histories of their prostate cancer patients.

Two electronic Clinical Quality Measures will help urologists report on prostate and bladder cancer care.


In a recent study, increasing hospital volume was significantly associated with improved perioperative outcomes.

Patients treated with pembrolizumab (Keytruda) as second-line therapy for advanced urothelial carcinoma following platinum-based chemotherapy maintain better health-related quality of life than their counterparts receiving chemotherapy, according to results from the phase III KEYNOTE-045 trial presented at the American Society of Clinical Oncology annual meeting in Chicago.

Despite technological advances in treatment for localized prostate cancer, men continue to experience clinically meaningful side effects that affect quality of life, according to an examination of data from a prospective population-based cohort study.

Metformin may act synergistically with androgen deprivation therapy to improve outcomes for men with advanced prostate cancer, according to findings of an observational study presented at the AUA annual meeting in Boston.


The proposed rule for MACRA and the Merit-based Incentive Payment System program was released June 21, 2017-- As expected, the program requiring the implementation of the new MIPS scoring system and incentives to move to alternative payment models will continue.

Nirmish Singla, MD, offers career planning tips to urology residents who may be approaching the end of their training.

In this Urology Times educational supplement, we review the changing relevance of PSA as prostate cancer advances through various stages.




Taller men and those with greater adiposity are at increased risk of having high-grade prostate cancer and of dying from their malignancy, according to recently published research.

Quality improvement programs address all aspects of care and care delivery. Here are a few programs that impact urology, all of which were presented at the AUA annual meeting in Boston.

The study of men with prostate cancer also found that the majority of the men with a germline cancer predisposition gene mutation did not meet existing criteria for clinical genetic testing.

Changes in health care have made quality improvement (QI) program participation more than a good idea. Today, QI activities are part of the alphabet soup of regulations impacting provider pay.

These videos each represent a different approach to this complex microsurgical procedure.

Electroacupuncture involving the lumbosacral region is safe, well-tolerated, and can reduce the amount of urine leakage in women with stress urinary incontinence, researchers reported.